PharmaResearch Co., Ltd. (KOSDAQ:214450)
578,000
+31,000 (5.67%)
Sep 26, 2025, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 6.01 trillion as of September 26, 2025. Its market cap has increased by 242.50% in one year.
Market Cap
6.01T
Enterprise Value
5.76T
Revenue
449.81B
Ranking
n/a
PE Ratio
47.22
Stock Price
578,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 6.01T, an increase of 495.01%. That is a compound annual growth rate of 19.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 6,005.22B | 120.19% |
Dec 30, 2024 | 2,727.28B | 144.17% |
Dec 28, 2023 | 1,116.95B | 60.18% |
Dec 29, 2022 | 697.32B | -14.76% |
Dec 30, 2021 | 818.02B | 48.15% |
Dec 30, 2020 | 552.15B | 60.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.45T |
Celltrion | 38.97T |
ALTEOGEN | 24.82T |
Yuhan | 8,985.05B |
SK Biopharmaceuticals | 8,403.01B |
Peptron | 6,552.18B |
LigaChem Biosciences | 5,698.46B |
Sam Chun Dang Pharm. | 5,500.39B |